Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Europeans Adults 60 Years of Age and Older

Sanofi Pasteur, a Sanofi Company · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
influenza immunization, healthy volunteers, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 880370
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.